Your browser doesn't support javascript.
loading
Racial disparities in rates of invasiveness of resected intraductal papillary mucinous neoplasms in the United States.
Allen, William E; Greendyk, Joshua D; Alexander, H Richard; Beninato, Toni; Eskander, Mariam F; Grandhi, Miral S; In, Haejin; Kennedy, Timothy J; Langan, Russell C; Maggi, Jason C; Moore, Dirk F; Pitt, Henry A; De, Subhajoyti; Haider, Syed F; Ecker, Brett L.
Afiliação
  • Allen WE; Rutgers New Jersey Medical School, Rutgers Health, Newark, NJ.
  • Greendyk JD; Rutgers New Jersey Medical School, Rutgers Health, Newark, NJ.
  • Alexander HR; Rutgers Cancer Institute of New Jersey, Rutgers Health, New Brunswick, NJ; Rutgers Robert Wood Johnson University Medical School, Rutgers Health, New Brunswick, NJ.
  • Beninato T; Rutgers Cancer Institute of New Jersey, Rutgers Health, New Brunswick, NJ; Rutgers Robert Wood Johnson University Medical School, Rutgers Health, New Brunswick, NJ.
  • Eskander MF; Rutgers Cancer Institute of New Jersey, Rutgers Health, New Brunswick, NJ; Rutgers Robert Wood Johnson University Medical School, Rutgers Health, New Brunswick, NJ.
  • Grandhi MS; Rutgers Cancer Institute of New Jersey, Rutgers Health, New Brunswick, NJ; Rutgers Robert Wood Johnson University Medical School, Rutgers Health, New Brunswick, NJ.
  • In H; Rutgers Cancer Institute of New Jersey, Rutgers Health, New Brunswick, NJ; Rutgers Robert Wood Johnson University Medical School, Rutgers Health, New Brunswick, NJ.
  • Kennedy TJ; Rutgers Cancer Institute of New Jersey, Rutgers Health, New Brunswick, NJ; Rutgers Robert Wood Johnson University Medical School, Rutgers Health, New Brunswick, NJ.
  • Langan RC; Rutgers Cancer Institute of New Jersey, Rutgers Health, New Brunswick, NJ; Rutgers Robert Wood Johnson University Medical School, Rutgers Health, New Brunswick, NJ; Cooperman Barnabas Medical Center, Livingston, NJ.
  • Maggi JC; Cooperman Barnabas Medical Center, Livingston, NJ.
  • Moore DF; Division of Biostatistics, Rutgers Cancer Institute of New Jersey, Rutgers Health, New Brunswick, NJ.
  • Pitt HA; Rutgers Cancer Institute of New Jersey, Rutgers Health, New Brunswick, NJ; Rutgers Robert Wood Johnson University Medical School, Rutgers Health, New Brunswick, NJ.
  • De S; Rutgers Cancer Institute of New Jersey, Rutgers Health, New Brunswick, NJ.
  • Haider SF; Department of Surgery, NYU Grossman School of Medicine, New York, NY.
  • Ecker BL; Rutgers Cancer Institute of New Jersey, Rutgers Health, New Brunswick, NJ; Rutgers Robert Wood Johnson University Medical School, Rutgers Health, New Brunswick, NJ; Cooperman Barnabas Medical Center, Livingston, NJ. Electronic address: Brett.Ecker@rutgers.edu.
Surgery ; 175(5): 1402-1407, 2024 May.
Article em En | MEDLINE | ID: mdl-38423892
ABSTRACT

BACKGROUND:

Racial and ethnic disparities have been observed in the multidisciplinary management of pancreatic ductal adenocarcinoma. Intraductal papillary mucinous neoplasm is the most common identifiable precursor to pancreatic ductal adenocarcinoma, where early surgical intervention before the development of an invasive intraductal papillary mucinous neoplasm improves survival. The association of race/ethnicity with the risk of identifying invasive intraductal papillary mucinous neoplasms during resection has not been previously defined.

METHODS:

The American College of Surgeons National Quality Improvement Program targeted pancreatectomy database (2014-2021) was queried for patients with race/ethnicity data who underwent resection of an intraductal papillary mucinous neoplasm. Backward Wald logistic regression modeling (P ≤ 0.05 for entry; P > .10 for removal) was used to identify independent predictors of invasion.

RESULTS:

A total of 4,505 cases of resected intraductal papillary mucinous neoplasms were identified, with 923 (20.5%) demonstrating invasive intraductal papillary mucinous neoplasms. The cohort of individuals other than non-Hispanic Whites were significantly more likely to have invasive intraductal papillary mucinous neoplasms (White, 19.9%; Black, 24.2%; Asian, 23.7%; Hispanic, 22.6%; P = .026). Such disparity could not be explained by greater comorbidity, as non-White patients were significantly younger (age <65 years 41.7% vs 33.2%, P < .001) and had better physical status (American Society of Anesthesiologists score ≤2 28.8% vs 25.2%, P = .053). After controlling for clinicodemographic variables, being an individual of race/ethnicity other than White was independently associated with higher odds of invasive intraductal papillary mucinous neoplasms (odds ratio, 1.280; 95% confidence interval, 1.046-1.566; P = .017). No differences in postoperative morbidity were observed.

CONCLUSION:

In a national cohort of patients with resected intraductal papillary mucinous neoplasms, individuals who identified as being of race/ethnicity other than White were significantly more likely to have invasive intraductal papillary mucinous neoplasms during surgical resection.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Císticas, Mucinosas e Serosas / Carcinoma Ductal Pancreático Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Císticas, Mucinosas e Serosas / Carcinoma Ductal Pancreático Idioma: En Ano de publicação: 2024 Tipo de documento: Article